KOZARICH JOHN W
SEC CIK 1223000 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LGND | LIGAND PHARMACEUTICALS INC | Dir | 42.6K | — | $2.38M | 24 | 2022-02-28 | 2026-06-05 |
Most active insiders at LGND, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Espinoza Octavio | CFO | — | $13.03M |
| 2 | Reardon Andrew | CLO, Sec | — | $8.77M |
| 3 | Haas Jason | Dir | — | $3.74M |
| 4 | LAMATTINA JOHN L | Dir | — | $2.44M |
| 5 | Gray Nancy Ryan | Dir | — | $1.35M |
| 6 | Aryeh Jason | Dir | — | $1.25M |
| 7 | KOZARICH JOHN W | Dir | — | $1.20M |
| 8 | Sabba Stephen L | Dir | — | $1.16M |
| 9 | Zimmermann Martine | Dir | — | $342.0K |
| 10 | Davis Todd C | CEO, Dir | — | — |
Transactions 24
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-09 19:40 | 2026-06-05 | LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Dir | A - Grant | $0.00 | +836 | 42.6K | +2% | $0 |
| DMT | 2026-05-14 21:08 | 2026-05-01+ | LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Dir | S - Sale+OE | $225.14 | -2,501 | 41.8K | -6% | -$563.1K |
| DMT | 2026-05-14 21:08 | 2026-05-12+ | LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Dir | M - OptEx | $69.51 | +2,034 | 43.4K | +5% | +$141.4K |
| MT | 2026-04-02 19:43 | 2026-04-01 | LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Dir | S - Sale | $202.23 | -467 | 42.3K | -1% | -$94.4K |
| M | 2026-03-04 | 2026-03-02 | LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Dir | S - Sale | $200.50 | -467 | 42.9K | -1% | -$93.6K |
| M | 2026-02-04 | 2026-02-02 | LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Dir | S - Sale | $195.91 | -467 | 43.6K | -1% | -$91.5K |
| M | 2026-01-06 | 2026-01-02 | LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Dir | S - Sale | $189.58 | -467 | 43.9K | -1% | -$88.5K |
| M | 2025-12-03 | 2025-12-01 | LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Dir | S - Sale | $195.84 | -467 | 44.2K | -1% | -$91.5K |
| M | 2025-11-05 | 2025-11-03 | LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Dir | S - Sale | $191.05 | -467 | 44.9K | -1% | -$89.2K |
| M | 2025-10-03 | 2025-10-01 | LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Dir | S - Sale | $179.45 | -467 | 45.5K | -1% | -$83.8K |
| M | 2025-09-04 | 2025-09-02 | LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Dir | S - Sale | $162.26 | -467 | 45.5K | -1% | -$75.8K |
| 2025-08-05 | 2025-08-01 | LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Dir | S - Sale | $131.88 | -467 | 46.0K | -1% | -$61.6K | |
| 2025-07-11 | 2025-07-10 | LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Dir | S - Sale | $125.00 | -934 | 46.5K | -2% | -$116.8K | |
| D | 2025-06-10 | 2025-06-06 | LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Dir | A - Grant | $0.00 | +1,209 | 47.4K | +3% | $0 |
| D | 2025-06-02 | 2025-01-17 | LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Dir | M - OptEx | $52.30 | +2,406 | 46.2K | +5% | +$125.8K |
| D | 2024-06-18 | 2024-06-14 | LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Dir | A - Grant | $0.00 | +1,252 | 43.8K | +3% | $0 |
| D | 2024-04-26 | 2024-04-24 | LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Dir | M - OptEx | $39.35 | +2,893 | 42.5K | +7% | +$113.8K |
| D | 2023-06-13 | 2023-06-09 | LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Dir | A - Grant | $0.00 | +1,142 | 39.6K | +3% | $0 |
| 2023-05-18 | 2023-05-16 | LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Dir | S - Sale | $77.20 | -4,444 | 38.5K | -10% | -$343.1K | |
| D | 2023-05-10 | 2023-05-08 | LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Dir | M - OptEx | $18.82 | +6,408 | 48.6K | +15% | +$120.6K |
| DM | 2023-05-10 | 2023-05-08 | LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Dir | S - Sale+OE | $76.56 | -6,408 | 42.8K | -13% | -$490.6K |
| D | 2022-06-13 | 2022-06-10 | LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Dir | A - Grant | $0.00 | +1,004 | 42.2K | +2% | $0 |
| D | 2022-03-01 | 2022-02-28 | LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Dir | M - OptEx | $12.53 | +7,335 | 42.1K | +21% | +$91.9K |
| D | 2022-03-01 | 2022-02-28 | LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Dir | S - Sale+OE | $102.62 | -908 | 41.2K | -2% | -$93.2K |
Purchase Sale Sale after option exercise All abbreviations